RhumbLine Advisers’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.79M | Buy |
|
|||||
|
2025
Q1 | $5.7M | Sell |
|
|||||
|
2024
Q4 | $5.07M | Buy |
|
|||||
|
2024
Q3 | $4.11M | Sell |
|
|||||
|
2024
Q2 | $3.56M | Buy |
|
|||||
|
2024
Q1 | $3.17M | Buy |
|
|||||
|
2023
Q4 | $2.93M | Sell |
|
|||||
|
2023
Q3 | $2.4M | Buy |
|
|||||
|
2023
Q2 | $4.3M | Buy |
|
|||||
|
2023
Q1 | $5.01M | Buy |
|
|||||
|
2022
Q4 | $3.88M | Buy |
|
|||||
|
2022
Q3 | $4.95M | Buy |
|
|||||
|
2022
Q2 | $3.59M | Buy |
|
|||||
|
2022
Q1 | $2.76M | Sell |
|
|||||
|
2021
Q4 | $2.95M | Sell |
|
|||||
|
2021
Q3 | $2.79M | Sell |
|
|||||
|
2021
Q2 | $3.21M | Buy |
|
|||||
|
2021
Q1 | $3.41M | Sell |
|
|||||
|
2020
Q4 | $4.92M | Buy |
|
|||||
|
2020
Q3 | $3.66M | Sell |
|
|||||
|
2020
Q2 | $5.04M | Buy |
|
|||||
|
2020
Q1 | $3.97M | Buy |
|
|||||
|
2019
Q4 | $4.22M | Buy |
|
|||||
|
2019
Q3 | $2.73M | Buy |
|
|||||
|
2019
Q2 | $3.59M | Buy |
|
|||||
|
2019
Q1 | $2.56M | Buy |
|
|||||
|
2018
Q4 | $2.07M | Buy |
|
|||||
|
2018
Q3 | $1.92M | Sell |
|
|||||
|
2018
Q2 | $1.47M | Buy |
|
|||||
|
2018
Q1 | $1.03M | Sell |
|
|||||
|
2017
Q4 | $654K | Sell |
|
|||||
|
2017
Q3 | $842K | Buy |
|
|||||
|
2017
Q2 | $711K | Sell |
|
|||||
|
2017
Q1 | $416K | Buy |
|
|||||
|
2016
Q4 | $449K | Sell |
|
|||||
|
2016
Q3 | $590K | Sell |
|
|||||
|
2016
Q2 | $346K | Buy |
|
|||||
|
2016
Q1 | $219K | Buy |
|
|||||
|
2015
Q4 | $1.08M | Buy |
|
|||||
|
2015
Q3 | $821K | Sell |
|
|||||
|
2015
Q2 | $1.49M | Buy |
|
|||||
|
2015
Q1 | $1.57M | Buy |
|
|||||
|
2014
Q4 | $1.1M | Buy |
|
|||||
|
2014
Q3 | $847K | Buy |
|
|||||
|
2014
Q2 | $500K | Buy |
|